Neuropeptide Y-ATP interactions and release at the vascular neuroeffector junction

Journal of Autonomic Pharmacology

Volumn 16, Issue 6, 1996, Pages 345-348

  Westfall, T C ^a   Yang, C L ^a   Rotto Perceley, D ^a   Macarthur, H ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BENEXTRAMINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y [14-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR AGONIST; POTASSIUM CHLORIDE; RECEPTOR SUBTYPE; SARAFOTOXIN S6C; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTERY PERFUSION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; MESENTERIC ARTERY; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PHEOCHROMOCYTOMA CELL; RAT; SMOOTH MUSCLE CONTRACTILITY;

EID: 0030426869     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.1996.tb00050.x     Document Type: Conference Paper

References (22)

1. ANDRIANTSITOHAINA, R. & STOCKIFT, JC. (1988). Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries. Br. J. Pharmacol., 95, 419-428.
2. BAX, W.A. & SAXENA, P.R. (1994). The current endothelial receptor classification: time for reconsideration. Trends Pharmacol. Sci., 15, 329-386.
3. COESSENS, B.C. (1994). Endothelin: an endothelium-derived vasoactive peptide. J. Reconst. Microsurg., 10, 405-410.
4. 1 receptor antagonist BIBP3226. J. Pharmacol Exp. Ther., 275, 136-142.
5. DOUGIAS, S.A., MEEN, T.D. & OHLSTEIN, E.H. (1994). Novel receptor antagonists welcome a new era in endothelin biology. Trends Pharmacol. Sci., 15, 31-316.
6. EDVINSSON, L., EKBLAD, F., HAKANSON, R. & WAHLESTEDI, C. (1984). Neuropeptide Y potentiates the effects of various vasoconstrictor agents on rabbit blood vessels. Br. J. Pharmacol., 83, 519-525
7. HILEY, C.R. (1995). Endothelin receptor ligands. Neurotransmissions., 11, 1-12.
8. IFVITT, B., HEAD, R. J. & WESTHALL, T.C. (1984). High pressure liquid chromatographic fluorometric detection of adenosine and adenosine nucleotides: application to endogenous content and electrically induced release of adenyl purines in guinea pig vas deferens. Anal. Biochem., 137, 93-100.
9. MCAULEY, M. & WESTEELL T.C. (1992). Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J. Pharmacol. Exp. Ther., 261, 863-868.
10. MORRIS, J.I. & BIBBINS, H. (1992). Co-transmission and neuromodulation. In: Autonomic Neuropeptide Mechanisms, pp. 33-119. Ed. J. Burnstock, & C.H.V. Hoyle. Harwood Academic Publishers, Reading, UK.
11. 2+ -dependent contraction by neuropeptide Y in rabbit mesenteric arteries. Gen. Pharmacol., 20, 363-367.
12. POTTER, F. (1991). Neuropeptide Y as an autonomic transmitter. In: Novel Peripheral Neurotransmitters, pp. 81-112. Ed. C. Bell. Pergamon Press, New York.
13. 1 receptor antagonist. Eur. J. Pharmacol., 271, R11-R13.
14. SAKURAL, T., YANAGISAWA, M. & MASAKI, T. (1992). Molecular characterization of endothelial receptors. Trends Pharmacol. Sci., 14, 54-60.
15. SECRIST, J.A., BARRIO, J.R., LEONARD, N.J. & WEBER, G. (1972). Fluorescent modification of adenosine containing coenzymes. Biological activities and spectroscopic properties. Biochem., 11, 3499-3506.
16. TABUCHI, Y., NAKAMARU, M., RAKUGI, H., NEGANO, M., MIKAMI, H. & (1989). Endothelin exhibits presynaptic adrenergic neurotransmission in rat mesenteric artery. Biochem. Biophys. Res. Comm., 161, 803-808.
17. WAHLESTEDT, L., EDRISSON, L., EKBLAD, F. & HAKANSON, R. (1985). Neuropeptide Y potentiates noradrenaline evoked vasoconstriction: mode of action. J. Pharmacol. Exp. Ther., 234, 735-741.
18. WESTFALL, T.C., CARPENTIER, S., CHEN, X., BEINFEID, M.C. NAES, L. & MELDRUN, M.I. (1987). Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J. Cardiovas. Pharmacol., 10, 716-722.
19. WESTFALL, T.C. HAN, S-P., DEI, VALLE, K., CUREMAN, M., CIARIEGLIO, A. & NAES, I., (1990). Presynaptic peptide receptors and hypertension. Ann. N. Y. Acad. Sci., 604, 372-388.
20. WHITE, T.D. (1991). Role of ATP and adenosine in the autonomic nervous septum. In: Novel Peripheral Neurotransmitters, pp. 9-64. Ed. C. Bell, Pergamon Press, New York.
21. 1 receptor antagonist BIBP 3226. J. Pharmacol. Exp. Ther., 275, 143-149.
22. WIKIUND, N.P., WIKLUND, C.I., CEDERQUIST, B., OHLEN, A., HEDQUIST, P. & GUSTAESSON, L.E. (1991). Endothelin modulation of neuroeffector Transmission in smooth muscle. J. Card. Pharmacol., 17 (Suppl), S335-S339.